DII
ANIK icon

Domini Impact Investments’s Anika Therapeutics ANIK Stock Holding History

Domini Impact Investments’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-5,955
Closed -$245K – 11
2014
Q1 		$245K Buy
5,955
+374
+7% +$13.9K 14.04% 3
2013
Q4 		$213K Buy
+5,581
New +$172K 15.51% 2

Other funds holding ANIK

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

Domini Impact Investments's ANIK Position: Q2 2014 in Review

Domini Impact Investments sold out of Anika Therapeutics (ANIK) in Q2 2014, closing a stake of 5,955 shares — an estimated $245K sold.

Domini Impact Investments first reported a position in ANIK in Q4 2013 and held it in 2 quarters. The position peaked at $245K in Q1 2014. 162 funds tracked by Wall St. Rank hold ANIK as of Q2 2014.

  • Domini Impact Investments reported no remaining Anika Therapeutics position as of Q2 2014 after selling out during the quarter.
  • Domini Impact Investments sold 5,955 Anika Therapeutics shares in Q2 2014, an estimated $245K.
  • Domini Impact Investments first reported a position in Anika Therapeutics in Q4 2013 and held it in 2 quarters.
  • Domini Impact Investments's Anika Therapeutics position peaked at $245K in Q1 2014.
  • 162 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2014.

Based on Domini Impact Investments's 13F filing for Q2 2014, filed 8 Aug 2014.